Fundz

Elanco Animal Health acquires Kindred Biosciences

PUBLIC · ELANJul 17, 2026

Acquiring Company

Elanco Animal Health

Acquired Company

Kindred Biosciences

IndianapolisSan FranciscoManufacturingBiotechnologyAgriculture and FarmingHealth CareAnimal FeedPetVeterinaryPharmaceutical ManufacturingBiotechnologyHealth CareBiopharma

Description

Elanco Animal Health has completed its acquisition of Kindred Biosciences for approximately $440 million. The deal reflects a total equity value that rewards shareholders for Kindred's advancements in veterinary biologics. The acquisition aims to enhance Elanco's product offerings in the growing veterinary therapeutics market.

Who to call at Elanco Animal Health, and when

When Elanco Animal Health changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Elanco Animal Health raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Elanco Animal Health, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Elanco Animal Health. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Elanco Animal Health

Location

450 Elanco Circle

Indianapolis, Indiana, United States

About

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy PurposeTM Sustainability Pledges –all to advance the health of animals, people, and the planet. Learn more at elanco.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Elanco Animal Health makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Aman
Senior decision-maker at this company
••••••••@••••••••

See Aman's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Elanco Animal Health's next move

Learn about Strategic plan

Frequently asked

Who acquired Kindred Biosciences?

Kindred Biosciences was acquired by Elanco Animal Health, based in Indianapolis. The deal was reported on July 17, 2026. Elanco Animal Health is publicly traded (ELAN) and operates in Manufacturing.

When did Elanco Animal Health acquire Kindred Biosciences?

Elanco Animal Health's acquisition of Kindred Biosciences was reported on July 17, 2026. Elanco Animal Health has completed its acquisition of Kindred Biosciences for approximately $440 million. The deal reflects a total equity value that rewards shareholders for Kindred's advancements in veterinary biologics. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Kindred Biosciences do?

Kindred Biosciences is a biopharmaceutical company dedicated to saving and improving the lives of animals. Specializing in developing innovative product therapies, they focus on veterinary medicines for companion animals. It is privately held, operating in Biotechnology, and is based in San Francisco.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.